Botanix Pharmaceuticals Limited (BOT.AX)
AUD 0.39
(1.3%)
AUD 0.39
(1.3%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 601.82 Thousand | 914.97 Thousand | 2.75 Million | 6.88 Million | 7.57 Million | 4.68 Million |
| Cost of Revenue | 7.15 Million | 3.96 Million | 143.49 Thousand | 94.22 Thousand | 102.28 Thousand | 1581.00 |
| Gross Profit | -6.55 Million | -3.04 Million | 2.61 Million | 6.79 Million | 7.47 Million | 4.68 Million |
| Operating Expenses | 601.82 Thousand | 9.74 Million | 15.79 Million | 10.17 Million | 24.15 Million | 21.84 Million |
| Selling, General and Administrative Expenses | 11.3 Million | 4.02 Million | 5.5 Million | 3.6 Million | 10.45 Million | 5.21 Million |
| Research and Development Expenses | 1.81 Million | 5.72 Million | 10.29 Million | 6.57 Million | 13.69 Million | 16.63 Million |
| Other Expenses | - | 3.65 Million | 2.77 Million | 6.88 Million | 7.39 Million | 4.3 Million |
| Cost and Expenses | 16.76 Million | 13.71 Million | 15.94 Million | 10.26 Million | 24.25 Million | 21.84 Million |
| Operating Income | -14.69 Million | -12.79 Million | -15.94 Million | -10.26 Million | -24.25 Million | -21.84 Million |
| Interest Expense | 10.65 Thousand | 81.73 Thousand | 37.44 Thousand | 55.94 Thousand | 50.98 Thousand | 11.2 Thousand |
| Income Tax Expense | - | -3.66 Million | -2.75 Million | -6.87 Million | -7.56 Million | -4.61 Million |
| Earnings before Tax | -13.86 Million | -12.82 Million | -15.92 Million | -10.21 Million | -24.29 Million | -21.65 Million |
| Net Income | -13.86 Million | -9.15 Million | -13.17 Million | -3.33 Million | -16.73 Million | -17.03 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.00 | -0.02 | -0.02 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.00 | -0.02 | -0.02 |
| Weighted Average Shares Outstanding | 1.5 Billion | 1.15 Billion | 973.14 Million | 972.93 Million | 936.37 Million | 760.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.5 Billion | 1.15 Billion | 973.14 Million | 972.93 Million | 936.37 Million | 760.76 Million |
| Gross Margin | -10.89 | -3.33 | 0.95 | 0.99 | 0.99 | 1.00 |
| EBIT Margin | -23.13 | -13.86 | -5.73 | -1.48 | -3.19 | -4.66 |
| Profit Margin | -23.05 | -10.00 | -4.78 | -0.48 | -2.21 | -3.64 |
| EBITDA | -13.91 Million | -9.1 Million | -15.74 Million | -10.06 Million | -24.14 Million | -17.15 Million |
| Earnings Before Tax Margin | -24.43 | -13.98 | -5.79 | -1.49 | -3.20 | -4.66 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.03 Million | 1.69 Million | 377.93 Thousand | 526.97 Thousand | 914.97 Thousand | 387.99 Thousand |
| Cost of Revenue | 7.15 Million | 2.67 Million | 3.4 Million | 2.71 Million | 3.96 Million | 1.24 Million |
| Gross Profit | -6.11 Million | -982.43 Thousand | -3.02 Million | -2.18 Million | -3.04 Million | -860.07 Thousand |
| Operating Expenses | 9.34 Million | 7.84 Million | 2.5 Million | 2.32 Million | 9.74 Million | 7.42 Million |
| Selling, General and Administrative Expenses | - | 7.01 Million | 1.52 Million | 1.69 Million | - | 2.33 Million |
| Research and Development Expenses | - | 834.73 Thousand | 978.2 Thousand | 636.67 Thousand | - | 5.09 Million |
| Other Expenses | -1.83 Million | -1.83 Million | - | - | 3.65 Million | - |
| Cost and Expenses | 16.49 Million | 10.52 Million | 5.9 Million | 5.04 Million | 13.71 Million | 8.66 Million |
| Operating Income | -15.45 Million | -8.83 Million | -5.52 Million | -4.51 Million | -12.79 Million | -8.28 Million |
| Interest Expense | 10.65 Thousand | 4032.00 | 6627.00 | 5064.00 | 81.73 Thousand | 76.67 Thousand |
| Income Tax Expense | -1.46 Million | -1.46 Million | -1.00 | 4.00 | -3.66 Million | -3.66 Million |
| Earnings before Tax | -15.33 Million | -8.4 Million | -5.46 Million | -4.55 Million | -12.82 Million | -8.26 Million |
| Net Income | -13.86 Million | -8.4 Million | -5.46 Million | -4.55 Million | -9.15 Million | -4.59 Million |
| Earnings Per Share Basic | - | -0.01 | -0.00 | -0.00 | - | -0.00 |
| Earnings Per Share Diluted | - | -0.01 | -0.00 | -0.00 | - | -0.00 |
| Weighted Average Shares Outstanding | 1.5 Billion | 1.56 Billion | 1.43 Billion | 1.31 Billion | 1.15 Billion | 1.02 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.5 Billion | 1.56 Billion | 1.43 Billion | 1.31 Billion | 1.15 Billion | 1.02 Billion |
| Gross Margin | -5.91 | -0.58 | -8.00 | -4.15 | -3.33 | -2.22 |
| EBIT Margin | - | -4.97 | -14.60 | -8.39 | - | -21.30 |
| Profit Margin | -13.41 | -4.97 | -14.47 | -8.65 | -10.00 | -11.85 |
| EBITDA | - | -8.4 Million | -5.51 Million | -4.42 Million | - | -8.26 Million |
| Earnings Before Tax Margin | -14.94 | -5.22 | -14.62 | -8.57 | -13.98 | -21.34 |
MOMT
3763
6140
EQT
NED
2053